Lithium (Li) is the first-line mood stabilizer to treat bipolar disorder patients. However, its mechanisms of action and transport across the blood-brain barrier remain poorly understood. In this study, we aimed at mapping ex vivo the cerebral Li distribution of rats treated for 28 days with Li2CO3 using 7Li-MRI at 17.2 Tesla. Using a phantom replacement approach, MRI-derived Li concentrations were calculated and validated by comparison to inductively coupled plasma-mass spectrometry (ICP-MS) measurements. Lithium distributions were uneven (normalized lithium content ranging from 0.7 to 1.4) and symmetrical with consistently lower concentrations in the metencephalon and higher ones in the cortex.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords